Although distinct Bregs populations, such as CD25+CD81High B7H-1High, PD-1- PD-L1 + CD19 + , and CD19+ CD25High CD69High have been described for breast cancer murine models30,78, 79, most studies use a single time point, preventing understand how tumor development influence these cells. This evidence concerns the gene CD19 and breast carcinoma.